A citation-based method for searching scientific literature

T Ashcroft, J M Simpson, V Timbrell. J Clin Pathol 1988
Times Cited: 885







List of co-cited articles
308 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Standardized quantification of pulmonary fibrosis in histological samples.
Ralf-Harto Hübner, Wolfram Gitter, Nour Eddine El Mokhtari, Micaela Mathiak, Marcus Both, Hendrik Bolte, Sandra Freitag-Wolf, Burkhard Bewig. Biotechniques 2008
253
12


Idiopathic pulmonary fibrosis.
Fernando J Martinez, Harold R Collard, Annie Pardo, Ganesh Raghu, Luca Richeldi, Moises Selman, Jeffrey J Swigris, Hiroyuki Taniguchi, Athol U Wells. Nat Rev Dis Primers 2017
294
12

Idiopathic pulmonary fibrosis.
Luca Richeldi, Harold R Collard, Mark G Jones. Lancet 2017
453
11

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
11

The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?
Antje Moeller, Kjetil Ask, David Warburton, Jack Gauldie, Martin Kolb. Int J Biochem Cell Biol 2008
557
9

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster,[...]. N Engl J Med 2014
9

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.
Ganesh Raghu, Bram Rochwerg, Yuan Zhang, Carlos A Cuello Garcia, Arata Azuma, Juergen Behr, Jan L Brozek, Harold R Collard, William Cunningham, Sakae Homma,[...]. Am J Respir Crit Care Med 2015
940
8

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
8

Idiopathic pulmonary fibrosis.
Talmadge E King, Annie Pardo, Moisés Selman. Lancet 2011
8

Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse.
S V Szapiel, N A Elson, J D Fulmer, G W Hunninghake, R G Crystal. Am Rev Respir Dis 1979
290
8

An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis.
R Gisli Jenkins, Bethany B Moore, Rachel C Chambers, Oliver Eickelberg, Melanie Königshoff, Martin Kolb, Geoffrey J Laurent, Carmel B Nanthakumar, Mitchell A Olman, Annie Pardo,[...]. Am J Respir Cell Mol Biol 2017
119
7

Developmental pathways in the pathogenesis of lung fibrosis.
Diptiman Chanda, Eva Otoupalova, Samuel R Smith, Thomas Volckaert, Stijn P De Langhe, Victor J Thannickal. Mol Aspects Med 2019
79
8

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Paul W Noble, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Marilyn K Glassberg, David Kardatzke, Talmadge E King, Lisa Lancaster, Steven A Sahn, Javier Szwarcberg,[...]. Lancet 2011
6

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu, Martine Remy-Jardin, Jeffrey L Myers, Luca Richeldi, Christopher J Ryerson, David J Lederer, Juergen Behr, Vincent Cottin, Sonye K Danoff, Ferran Morell,[...]. Am J Respir Crit Care Med 2018
6

Clinical course and prediction of survival in idiopathic pulmonary fibrosis.
Brett Ley, Harold R Collard, Talmadge E King. Am J Respir Crit Care Med 2011
852
5

The importance of interventional timing in the bleomycin model of pulmonary fibrosis.
Philipp Kolb, Chandak Upagupta, Megan Vierhout, Ehab Ayaub, Pierre Simon Bellaye, Jack Gauldie, Chiko Shimbori, Mark Inman, Kjetil Ask, Martin R J Kolb. Eur Respir J 2020
17
29

Participation of miR-200 in pulmonary fibrosis.
Shanzhong Yang, Sami Banerjee, Andressa de Freitas, Yan Y Sanders, Qiang Ding, Sadis Matalon, Victor J Thannickal, Edward Abraham, Gang Liu. Am J Pathol 2012
168
4

The impact of TGF-β on lung fibrosis: from targeting to biomarkers.
Isis E Fernandez, Oliver Eickelberg. Proc Am Thorac Soc 2012
338
4

Murine models of pulmonary fibrosis.
Bethany B Moore, Cory M Hogaboam. Am J Physiol Lung Cell Mol Physiol 2008
497
4

Molecular and cellular mechanisms of pulmonary fibrosis.
Nevins W Todd, Irina G Luzina, Sergei P Atamas. Fibrogenesis Tissue Repair 2012
216
4

Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis.
Jun Tashiro, Sharon J Elliot, David J Gerth, Xiaomei Xia, Simone Pereira-Simon, Rhea Choi, Paola Catanuto, Shahriar Shahzeidi, Rebecca L Toonkel, Rahil H Shah,[...]. Transl Res 2015
47
8

Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for "active" disease.
Ruoqi Peng, Sriram Sridhar, Gaurav Tyagi, Jonathan E Phillips, Rosario Garrido, Paul Harris, Lisa Burns, Lorena Renteria, John Woods, Leena Chen,[...]. PLoS One 2013
112
4

NLRP3 participates in the regulation of EMT in bleomycin-induced pulmonary fibrosis.
Rui Tian, Yong Zhu, Jiayi Yao, Xiaoxiao Meng, Jinfeng Wang, Hui Xie, Ruilan Wang. Exp Cell Res 2017
44
9

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy.
Peter M George, Athol U Wells, R Gisli Jenkins. Lancet Respir Med 2020
313
4

The Bleomycin Model of Pulmonary Fibrosis.
Tianju Liu, Francina Gonzalez De Los Santos, Sem H Phan. Methods Mol Biol 2017
70
5

Time course of bleomycin-induced lung fibrosis.
G Izbicki, M J Segel, T G Christensen, M W Conner, R Breuer. Int J Exp Pathol 2002
241
3

Synergistic protection of Schizandrin B and Glycyrrhizic acid against bleomycin-induced pulmonary fibrosis by inhibiting TGF-β1/Smad2 pathways and overexpression of NOX4.
Di Zhang, Bin Liu, Bo Cao, Fei Wei, Xin Yu, Guo-Feng Li, Hong Chen, Lu-Qing Wei, Pei-Lan Wang. Int Immunopharmacol 2017
18
16

Idiopathic pulmonary fibrosis: pathogenesis and management.
Giacomo Sgalla, Bruno Iovene, Mariarosaria Calvello, Margherita Ori, Francesco Varone, Luca Richeldi. Respir Res 2018
128
3


ONO-1714, a nitric oxide synthase inhibitor, attenuates endotoxin-induced acute lung injury in rabbits.
Katsuya Mikawa, Kahoru Nishina, Yumiko Takao, Hidefumi Obara. Anesth Analg 2003
97
3

Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice.
Yoshinori Aono, Yasuhiko Nishioka, Mami Inayama, Momoyo Ugai, Jun Kishi, Hisanori Uehara, Keisuke Izumi, Saburo Sone. Am J Respir Crit Care Med 2005
173
3

Molecular mechanisms of epithelial-mesenchymal transition.
Samy Lamouille, Jian Xu, Rik Derynck. Nat Rev Mol Cell Biol 2014
3

Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis.
Lutz Wollin, Isabelle Maillet, Valérie Quesniaux, Alexander Holweg, Bernhard Ryffel. J Pharmacol Exp Ther 2014
295
3

Increased Extracellular Vesicles Mediate WNT5A Signaling in Idiopathic Pulmonary Fibrosis.
Aina Martin-Medina, Mareike Lehmann, Olivier Burgy, Sarah Hermann, Hoeke A Baarsma, Darcy E Wagner, Martina M De Santis, Florian Ciolek, Thomas P Hofer, Marion Frankenberger,[...]. Am J Respir Crit Care Med 2018
57
5


Comprehensive microRNA analysis in bleomycin-induced pulmonary fibrosis identifies multiple sites of molecular regulation.
Ting Xie, Jiurong Liang, Rishu Guo, Ningshan Liu, Paul W Noble, Dianhua Jiang. Physiol Genomics 2011
79
3

miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis.
Gang Liu, Arnaud Friggeri, Yanping Yang, Jadranka Milosevic, Qiang Ding, Victor J Thannickal, Naftali Kaminski, Edward Abraham. J Exp Med 2010
653
3

Inhibition and role of let-7d in idiopathic pulmonary fibrosis.
Kusum V Pandit, David Corcoran, Hanadie Yousef, Manohar Yarlagadda, Argyris Tzouvelekis, Kevin F Gibson, Kazuhisa Konishi, Samuel A Yousem, Mandal Singh, Daniel Handley,[...]. Am J Respir Crit Care Med 2010
357
3

Amnion Epithelial Cell-Derived Exosomes Restrict Lung Injury and Enhance Endogenous Lung Repair.
Jean L Tan, Sin N Lau, Bryan Leaw, Hong P T Nguyen, Lois A Salamonsen, Mohamed I Saad, Siow T Chan, Dandan Zhu, Mirja Krause, Carla Kim,[...]. Stem Cells Transl Med 2018
78
3

Exosomes: composition, biogenesis and function.
Clotilde Théry, Laurence Zitvogel, Sebastian Amigorena. Nat Rev Immunol 2002
3


Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical Trial.
Marilyn K Glassberg, Julia Minkiewicz, Rebecca L Toonkel, Emmanuelle S Simonet, Gustavo A Rubio, Darcy DiFede, Shirin Shafazand, Aisha Khan, Marietsy V Pujol, Vincent F LaRussa,[...]. Chest 2017
107
3

Anti-inflammatory effects of adult stem cells in sustained lung injury: a comparative study.
Yuben Moodley, Vijesh Vaghjiani, James Chan, Svetlana Baltic, Marisa Ryan, Jorge Tchongue, Chrishan S Samuel, Padma Murthi, Ornella Parolini, Ursula Manuelpillai. PLoS One 2013
72
4

Reversal of bleomycin-induced rat pulmonary fibrosis by a xenograft of human umbilical mesenchymal stem cells from Wharton's jelly.
Kuo-An Chu, Shih-Yao Wang, Chang-Ching Yeh, Tz-Win Fu, Yu-Yi Fu, Tsui-Ling Ko, Mei-Miao Chiu, Tien-Hua Chen, Pei-Jiun Tsai, Yu-Show Fu. Theranostics 2019
17
17

Idiopathic pulmonary fibrosis: aberrant recapitulation of developmental programs?
Moisés Selman, Annie Pardo, Naftali Kaminski. PLoS Med 2008
239
3

Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis.
Martin Kolb, Ganesh Raghu, Athol U Wells, Jürgen Behr, Luca Richeldi, Birgit Schinzel, Manuel Quaresma, Susanne Stowasser, Fernando J Martinez. N Engl J Med 2018
99
3

Transforming growth factor beta in tissue fibrosis.
W A Border, N A Noble. N Engl J Med 1994
3

Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
Sun Young Kyung, Dae Young Kim, Jin Young Yoon, Eun Suk Son, Yu Jin Kim, Jeong Woong Park, Sung Hwan Jeong. BMC Pharmacol Toxicol 2018
29
10

FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis.
Hamza M Al-Tamari, Swati Dabral, Anja Schmall, Pouya Sarvari, Clemens Ruppert, Jihye Paik, Ronald A DePinho, Friedrich Grimminger, Oliver Eickelberg, Andreas Guenther,[...]. EMBO Mol Med 2018
41
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.